688319 歐林生物
按盤價 
30.880 +0.940 (+3.140%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.964 | 2.435 | 2.254 | 1.952 | 3.079 |
| 總資產報酬率 ROA (%) | 1.345 | 1.162 | 1.214 | 1.136 | 1.975 |
| 投入資產回報率 ROIC (%) | 1.978 | 1.680 | 1.693 | 1.602 | 2.763 | 邊際利潤分析 |
| 銷售毛利率 (%) | 91.841 | 92.959 | 94.446 | 93.550 | 92.865 |
| 營業利潤率 (%) | 20.527 | 4.382 | 3.619 | 0.625 | 7.601 |
| 息稅前利潤/營業總收入 (%) | 23.216 | 6.586 | 5.488 | 4.091 | 8.212 |
| 淨利潤/營業總收入 (%) | 17.235 | 3.110 | 2.670 | 2.306 | 4.854 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 65.779 | 141.229 | 84.567 | 33.731 | 67.609 |
| 價值變動淨收益/利潤總額(%) | 0.386 | 1.561 | 3.836 | 6.671 | 8.478 |
| 營業外收支淨額/利潤總額(%) | 0.092 | 3.248 | 4.454 | 80.159 | 4.656 | 償債能力分析 |
| 流動比率 (X) | 1.355 | 1.352 | 1.525 | 1.955 | 1.782 |
| 速動比率 (X) | 1.265 | 1.267 | 1.381 | 1.804 | 1.632 |
| 資產負債率 (%) | 53.900 | 55.316 | 48.341 | 42.282 | 39.694 |
| 帶息債務/全部投入資本 (%) | 29.028 | 29.244 | 26.115 | 18.658 | 11.303 |
| 股東權益/帶息債務 (%) | 230.772 | 227.286 | 274.486 | 422.883 | 757.413 |
| 股東權益/負債合計 (%) | 85.500 | 80.751 | 105.854 | 134.475 | 150.186 |
| 利息保障倍數 (X) | 8.694 | 3.202 | 3.227 | 4.335 | 34.304 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 388.432 | 312.370 | 323.304 | 356.438 | 272.293 |
| 存貨周轉天數 (天) | 450.323 | 537.553 | 868.416 | 847.387 | 705.108 |
| 備註： | 即時報價更新時間為 30/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
